Hormonal
Consuming one additional serving per day of sugar-sweetened beverages (SSB) increases the relative risk of incident hypertension by 8% and coronary heart disease (CHD) by 17%.
To lower your risk of high blood pressure and heart disease, aim to reduce your daily intake of sugar-sweetened beverages. Each serving you cut back can significantly lower your risk. Focus on replacing these drinks with water or unsweetened alternatives, as the sugar and fructose in sodas and sweet teas drive inflammation and blood pressure issues.
The summary RR for incident hypertension was 1·08 (95 % CI 1·04, 1·12) for every additional one serving/d increase in SSB consumption. The summary RR for incident CHD was 1·17 (95 % CI 1·10, 1·24) for every serving/d increase in SSB consumption.
Why this rating
High-quality prospective cohort meta-analysis with large sample sizes, though observational design limits causal inference compared to RCTs.
Source
Sugar-sweetened beverages and risk of hypertension and CVD: a dose–response meta-analysis
Bo Xi et al. · British Journal Of Nutrition · 2015
DOI 10.1017/s0007114514004383
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →